ID

20334

Description

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Lien

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Mots-clés

Versions (2)
  1. 15/02/2017 15/02/2017 -
  2. 20/02/2017 20/02/2017 -
Téléchargé le

20 février 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Inclusion Exclusion Randomization Trial Drug Administration PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Anglais

Inclusion Exclusion Randomization Trial Drug Administration PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulaires  
Inclusion Exclusion Criteria
Description

Inclusion Exclusion Criteria

Alias
UMLS CUI-1
C1512693
UMLS CUI-3
C0680251
Did the subject meet all the entry criteria at the time of enrollment (see opposite page)
Description

Entry criteria

Type de données

boolean

Alias
UMLS CUI [1]
C1516637
If no, please give line number(s) of the corresponding criteria not met
Description

Numbers of the corresponding criteria

Type de données

text

Randomisation
Description

Randomisation

Alias
UMLS CUI-1
C0034656
Date of randomisation using IVRS (dd mon yy)
Description

Date of randomisation

Type de données

date

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0011008
Trial Drug Administration
Description

Trial Drug Administration

Alias
UMLS CUI-1
C3469597
Will the trial medication kit be dispensed to the patient?
Description

Trial medication kit

Type de données

boolean

Alias
UMLS CUI [1]
C0013227
If YES, provide patient with trial medication kit assigned by IVRS. Stick the label from trial medication kit below. If label is lost, please enter assigned medication number below:
Description

If yes

Type de données

text

Alias
UMLS CUI [1]
C2360065
UMLS CUI [2]
C1521902
If NO, primary reason for not dispensing trial drug (indicate one)
Description

If NO

Type de données

integer

Alias
UMLS CUI [1]
C1521902
Explain other:
Description

Other

Type de données

text

Alias
UMLS CUI [1]
C1521902
Preparation For Next Visit
Description

Preparation For Next Visit

Alias
UMLS CUI-1
C1521827
UMLS CUI-2
C1522577
Investigator´s Declaration By signing and dating this page, I declare that I have reviewed for accuracy all the case report form pages for this patient; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed on the specified dates.
Description

Investigator´s Declaration

Type de données

text

Signature by investigator
Description

Signature

Type de données

text

Alias
UMLS CUI [1]
C2346576
Date (dd mon yy)
Description

Investigator Signature Date

Type de données

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Retour au début de la page

Similar models

Inclusion Exclusion Randomization Trial Drug Administration PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Exclusion Criteria
C1512693 (UMLS CUI-1)
C0680251 (UMLS CUI-3)
Entry criteria
Item
Did the subject meet all the entry criteria at the time of enrollment (see opposite page)
boolean
C1516637 (UMLS CUI [1])
Numbers of the corresponding criteria
Item
If no, please give line number(s) of the corresponding criteria not met
text
Item Group
Randomisation
C0034656 (UMLS CUI-1)
Date of randomisation
Item
Date of randomisation using IVRS (dd mon yy)
date
C0034656 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Trial Drug Administration
C3469597 (UMLS CUI-1)
Trial medication kit
Item
Will the trial medication kit be dispensed to the patient?
boolean
C0013227 (UMLS CUI [1])
If yes
Item
If YES, provide patient with trial medication kit assigned by IVRS. Stick the label from trial medication kit below. If label is lost, please enter assigned medication number below:
text
C2360065 (UMLS CUI [1])
C1521902 (UMLS CUI [2])
Item
If NO, primary reason for not dispensing trial drug (indicate one)
integer
C1521902 (UMLS CUI [1])
If NO
Code List
If NO, primary reason for not dispensing trial drug (indicate one)
CL Item
Adverse event (1)
CL Item
Inclusion / Exclusion criteria not met (2)
CL Item
Lost follow-up (3)
CL Item
Consent withdrawn (not due to adverse event) (4)
CL Item
Other (explain below) (5)
Other
Item
Explain other:
text
C1521902 (UMLS CUI [1])
Item Group
Preparation For Next Visit
C1521827 (UMLS CUI-1)
C1522577 (UMLS CUI-2)
Investigator´s Declaration
Item
Investigator´s Declaration By signing and dating this page, I declare that I have reviewed for accuracy all the case report form pages for this patient; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed on the specified dates.
text
Signature
Item
Signature by investigator
text
C2346576 (UMLS CUI [1])
Investigator Signature Date
Item
Date (dd mon yy)
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial